GeneDx Holdings (WGS) Non Operating Income (2020 - 2026)

GeneDx Holdings has disclosed Non Operating Income across 7 years of filings, most recently posting -$4.9 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 223.19% year-over-year to -$4.9 million; the TTM figure through Mar 2026 stood at -$15.8 million (up 20.46% YoY), while the FY2025 annual figure was -$8.1 million, up 38.07% from the prior year.
• Non Operating Income rose to -$4.9 million in Q1 2026, from -$8.3 million in the prior quarter.
• Over the last five years, Non Operating Income for WGS reached as high as $27.8 million in Q2 2022 and fell as low as -$18.8 million in Q2 2024.
• The 5-year median for Non Operating Income is -$269500.0 (2022), against an average of $594125.0.
• Annual changes were most pronounced in 2022 — Non Operating Income jumped 4003.23% — and 2023, when it sank 56800.0%.
• A 5-year view of Non Operating Income shows it stood at $16.2 million in 2022, then sank by 103.34% to -$541000.0 in 2023, then plunged by 31.98% to -$714000.0 in 2024, then slumped by 1067.23% to -$8.3 million in 2025, then soared by 40.63% to -$4.9 million in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered -$4.9 million, -$8.3 million, and -$4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.